Operating Expenses: The sum of all operating expenses for the given industry.
Aptevo Therapeutics Inc. (APVO) had Operating Expenses of $26.31M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-27.54M |
|
-- |
|
-- |
|
|
Operating Expenses |
$26.31M |
$-26.31M |
|
$0.34M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-26.31M |
|
$-26.07M |
|
0.32M |
|
0.32M |
|
$-87.27 |
|
$-87.27 |
|
| Balance Sheet Financials | |
$23.08M |
|
$0.30M |
|
$4.11M |
|
$27.19M |
|
$6.05M |
|
-- |
|
$3.76M |
|
$9.81M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
1.00M |
|
| Cash Flow Statement Financials | |
$-25.59M |
|
-- |
|
$38.50M |
|
$8.71M |
|
$21.62M |
|
$12.90M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-149.40% |
|
-149.40% |
|
-95.49% |
|
-149.40% |
|
$17.42 |
|
$-81.11 |
|
$-81.11 |
|